Canadian Cancer Survivor Network
  • About Us
    • Mission and Vision
    • Our Team
    • Annual Reports
    • Advisory Councils
    • Medical Advisory Committee
    • Friends Remembered
  • News
  • Events
  • BLOG
  • E-Letters
  • Partners
  • Media
  • Contact Us
  • DONATE
  • Connect
    • Our Team
    • Advisory Councils
    • Medical Advisory Committee
    • Get Involved
    • Friends Remembered
    • Partners
  • Learn
    • The Science of Cancer Online Course
    • Cancer Types
    • Issues Affecting Cancer Patients
    • Issues Affecting Cancer Survivors
    • Cancer Months
    • Medicare
    • Cancer Centres
  • Act
    • CCSN Webinar Series
    • CCSN Election Campaigns
    • Participate
    • Campaigns for Better Healthcare
    • Cancer Can’t Wait: Covid-19 Disruption of Cancer Care
    • What Cancer Patients Should Know About COVID-19
    • Right2Survive
    • Protect Our Access
    • Precision Medicines & Diagnostic Testing
  • Connect
    • Our Team
    • Advisory Councils
    • Medical Advisory Committee
    • Get Involved
    • Friends Remembered
    • Partners
  • Learn
    • The Science of Cancer Online Course
    • Cancer Types
    • Issues Affecting Cancer Patients
    • Issues Affecting Cancer Survivors
    • Cancer Months
    • Medicare
    • Cancer Centres
  • Act
    • CCSN Webinar Series
    • CCSN Election Campaigns
    • Participate
    • Campaigns for Better Healthcare
    • Cancer Can’t Wait: Covid-19 Disruption of Cancer Care
    • What Cancer Patients Should Know About COVID-19
    • Right2Survive
    • Protect Our Access
    • Precision Medicines & Diagnostic Testing
  • About Us
    • Mission and Vision
    • Our Team
      • Board of Directors
    • Annual Reports
    • Advisory Councils
    • Medical Advisory Committee
    • Friends Remembered
  • News
  • Events
  • BLOG
  • E-Letters
  • Partners
  • Media
  • Contact Us
  • DONATE
Canadian Cancer Survivor Network/Learn/Issues Affecting Cancer Survivors/Personal Experiences When Dealing With Cancer

Personal Experiences When Dealing With Cancer

This section will outline ways to navigate various personal experiences during or after cancer treatment.

If you feel we have missed an important issue, please contact us so we can work on adding it.

  • Caregivers
  • Childhood cancer survivorship
  • Coping with fear
  • Nutrition
  • Post-cancer emotional growth
  • Pregnancy after cancer
  • Relationships and cancer
  • Sexual relations
  • Spirituality
  • Talking with your partner
  • Work and financial aspects of survivorship

Learn

  • Cancer Types
  • Issues Affecting Cancer Patients
    • Asbestos and mesothelioma
      • The ABCs of asbestos
        • What is asbestos
        • The uses of asbestos
        • The pre-industrial history of asbestos
      • Mesothelioma
      • Federal regulations banning asbestos in Canada
      • How you can be exposed to asbestos
      • Mesothelioma organizations
        • Canadian asbestos and mesothelioma organizations
        • International asbestos and mesothelioma organizations
    • Blood clots and cancer
    • Bone metastases
    • Caregivers
      • How I Learned to Be A Cancer Caregiver
    • Chemo-induced nausea and vomiting (CINV)
      • Chemo-induced nausea and vomiting (CINV) resources
      • A patient charter for CINV management (UK)
      • What is chemo-induced nausea and vomiting?
      • Provincial resources for managing CINV
    • Clinical Trials
      • Biomarkers
    • Drug approval in Canada
      • Québec
      • Health Canada Health Products and Food Branch
      • pan-Canadian Oncology Drug Review (pCODR)
    • Drug pricing policy in Canada
      • Drug Pricing in Canada: mobilizing patients to action – Recap
      • PDF’s from 2016 Summit
    • Drug safety in Canada
    • Financial cost of cancer
      • Key Informant Interview: A View From the Front Lines
      • Work and Cancer
      • The Financial Hardship of Cancer in Canada: A Literature Review
      • Financial hardship of cancer in Canada: a call for action
      • Financial help
        • Newfoundland & Labrador
        • British Columbia
        • Alberta
        • Yukon
        • Saskatchewan
        • Quebec
        • Prince Edward Island
        • Ontario
        • Nunavut
        • Nova Scotia
        • Northwest Territories
        • New Brunswick
        • Manitoba
    • Genetic testing
      • Alberta
      • British Columbia
      • Manitoba
      • Maritime Provinces
      • Newfoundland and Labrador
      • Northwest Territories
      • Nunavut
      • Ontario
      • Quebec
      • Saskatchewan
      • Yukon
    • Febrile Neutropenia
    • HPV and cancer
      • Canadian organizations mark the first annual international HPV awareness day: Give love, not HPV
      • HPV vaccine expanded to include ‘at-risk’ boys
      • Key points for policy-makers and health professionals
      • WHO Information on Human papillomavirus (HPV) and cervical cancer
      • Human Papillomavirus and Related Cancers in Canada, Fact Sheet 2010
      • Reframing the debate
      • WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer
    • Insurance and cancer
    • LGBTQ+ issues
    • Lymphedema
      • Lymphedema Groups in Canada
      • International Lymphedema Groups
    • Medical Cannabis
      • Information on Medical Cannabis
        • Part One: Why Cannabis Works
        • Part Two: Medical Conditions & Products
        • Part Three: Accessing Medical Cannabis
        • Part Four: Medical Cannabis Myths & Facts
        • PDQ Cancer Information Summaries
          • History
          • Laboratory, animal and preclinical Studies
          • Human and clinical studies
          • Adverse effects
          • Summary of the evidence
          • About this PDQ summary
        • Medical Cannabis Infographics
        • Medicinal cannabis: Used throughout the ages for medicinal, therapeutic and religious purposes
        • Cannabinoids: The chemical components of cannabis
        • Potential therapeutic uses of medical cannabis
        • Medical cannabis strains
        • Cannabis contamination
        • Want to learn more about the science of medical cannabis?
        • Webinars & Slideshows
        • Glossary of terms
      • Medical Cannabis “How To”
        • How To: Tell the Difference Between Medical Cannabis & Medical Marijuana
        • How To: Use Medical Cannabis
        • How To: Talk to your Doctor about Medical Cannabis
        • How To: Travel with Medical Cannabis
      • Medical Cannabis in the Media
        • High Standards: A Blueprint for the Marijuana Market in Canada
        • Canada introduces legal access
        • Medical Cannabis podcasts
        • Further Readings
      • Patient Stories
      • Health Canada Reports Increasing Use Of Cannabis And Cannabis Vaporization
      • Canadian Cancer Survivor Network Submission : Task Force on Marijuana Legalization and Regulation
      • A Framework for the Legalization and Regulation of Cannabis in Canada
    • Tumour Agnostic Treatments and Companion Diagnostics
      • Companion Diagnostics in Canada
      • Tumour-Agnostic Treatments
    • Mental Wellness
    • New treatments
      • ALECENSARO® (alectinib) approved by Health Canada for first-line treatment of ALK-positive lung cancer
      • AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer
      • First and Only Immuno-Oncology Treatment, Imfinzi® (durvalumab), for Stage III, Unresectable Non-Small Cell Lung Cancer Now Approved in Canada
      • Health Canada Approves ERLEADA™* (apalutamide tablets), the First Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer
      • Health Canada Approves GAZYVA® for Previously Untreated Advanced Follicular Lymphoma
      • Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)
      • Health Canada approves KISQALI™ for the treatment of HR-positive and HER2-negative metastatic breast cancer in postmenopausal women in combination with letrozole as an initial endocrine-based therapy
      • Health Canada approves PERJETA® (pertuzumab) for the treatment of HER2-positive early breast cancer after surgery
      • Health Canada Approves Tagrisso® (osimertinib) as First-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer
      • Health Canada approves TECENTRIQ® (atezolizumab) for the treatment of patients with metastatic non-small cell lung cancer
      • Health Canada Approves XTANDI® (enzalutamide) – the First and Only Oral Treatment for Men with Non-Metastatic and Metastatic Castration-Resistant Prostate Cancer
      • Lynparza® (olaparib) Receives New Indication for BRCA-Mutated Metastatic Breast Cancer
      • Lynparza® (olaparib) tablets receive approval as maintenance therapy treatment for ovarian cancer regardless of BRCA status
      • Novartis receives Health Canada approval for the combination therapy of Tafinlar® (dabrafenib) plus Mekinist® (trametinib) for adjuvant treatment of patients with BRAF V600 mutation melanoma(i)
      • Only Immuno-Oncology Combination Therapy Approved by Health Canada as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma
      • Health Canada Approves RITUXAN® Subcutaneous Formulation for Canadians with Chronic Lymphocytic Leukemia
      • Health Canada Approves New Indication for ZYTIGA®* (abiraterone acetate), Broadening its Use for Treatment of Newly Diagnosed Metastatic Prostate Cancer
      • Taiho Pharma Canada, Inc. announces Health Canada approval of LONSURF® (trifluridine and tipiracil tablets) for metastatic colorectal cancer
      • Tagrisso® (osimertinib) receives full Health Canada approval for targeted treatment of non-small cell lung cancer
      • Quebec and New Brunswick Become First Provinces to Provide Public Funding of IBRANCE™ for the First-Line Treatment of Metastatic Breast Cancer
    • Palliative Care
      • Palliative care services and resources
    • Prevention
      • Alcohol use
      • Vitamin D
      • Tobacco
      • Radiation
      • Prophylactic surgery and cancer prevention
      • Environmental pollution
      • Occupational carcinogens
      • Infections
      • Physical inactivity, dietary factors, obesity and being overweight
    • Research resources
    • Wait times in Canada
      • Wait Times – Fraser Institute Report December 2017
      • Wait Times Alliance Report Card 2014: Time to Close the Gap
      • Canadian Institute for Health Information
      • Wait Times in Canada— A Summary, 2012
      • Wait Times Alliance
      • Wait Times – Fraser Institute Report December 2016
      • Provincial and Territorial wait times
  • Issues Affecting Cancer Survivors
    • Survivorship Issues
      • Health Data Should Follow Patients
      • Anorexia
      • Brain Fog
      • Cardiovascular Changes
      • Deconditioning
      • Diabetes
      • Disfigurement and Amputation
      • Fatigue
      • Function and Mobility
      • Hair Loss (Alopecia)
      • Impotence
      • Urinary Incontinence
      • Infertility
      • Lymphedema
      • Mood disorders
      • Bone Loss
      • Ostomy
      • Pain
      • Post-Traumatic Stress Disorder (PTSD)
      • Secondary Malignancies and Recurrence
      • Swallowing and Speech
      • Work Productivity
    • Personal Experiences When Dealing With Cancer
      • Caregivers
      • Childhood cancer survivorship
      • Coping with fear
      • Nutrition
      • Post-cancer emotional growth
      • Pregnancy after cancer
      • Relationships and cancer
      • Sexual relations
      • Spirituality
      • Talking with your partner
      • Work and financial aspects of survivorship
    • Cancer Rehabilitation
      • Canadian Context
      • Gaps in Rehabilitation
      • Statistics Across Canada
        • Alberta
        • British Columbia
        • Manitoba
        • Nova Scotia
        • Nunavut
        • Ontario
        • Quebec
        • Saskatchewan
    • Living Healthy
    • Canadian Organizations
    • USA Organizations
  • Cancer Centres
    • Prince Edward Island
    • Yukon
    • Quebec
    • Ontario
    • Nunavut
    • Nova Scotia
    • Northwest Territories
    • Newfoundland and Labrador
    • Saskatchewan
    • New Brunswick
    • Manitoba
    • British Columbia
    • Alberta
  • Medicare
    • Newfoundland and Labrador
    • Alberta
    • Northwest Territories
    • Government of Canada
    • Nova Scotia
    • Nunavut
    • Ontario
    • Prince Edward Island
    • Quebec
    • New Brunswick
    • Saskatchewan
    • Yukon
    • Manitoba
    • British Columbia
  • Cancer Months
Canadian Cancer Survivor Network
  • E-Letters
  • News
  • Partners
  • Events
  • Media

Groups

  • Cancer Centres
  • Cancer Types
  • Medicare
  • Get Involved

Contact

For more information,
Please contact us at
(613) 898-1871
or email us at
info@survivornet.ca

Get Connected

Charitable registration number:
83454 0882 RR0001

Stay Informed